Evidence map›Paper›PMID 42650799›Full record

ReviewBiomolecules2026

Host-Dependent Medicinal Quality of Taxilli Herba: A Comprehensive Review on Chemical Profiles and Bioactivities.

Mei Ru, Rong Su, Min Guo, Zhihui Yin, Wendong Li, Ping Li, Zishu Chai, Yonghua Li

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mei RuCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.
Rong SuCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.
Min GuoCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.
Zhihui YinCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.
Wendong LiCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.
Ping LiCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.
Zishu ChaiCenxi Sangjisheng Agri-Tech Courtyard, Cenxi 543200, China.
Yonghua LiCollege of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China.ORCID 0000-0002-4386-789X

Funding

Guangxi Science and Technology Department Guike FN2600640125Guangxi University of Chinese Medicine Gui Ke Ji Zi [2005] No.6National Natural Science Foundation of China No. 82160754
6 · The paper itself

Abstract

Taxilli Herba (Sangjisheng) is a hemi-parasitic medicinal plant whose quality is intrinsically linked to its host species. While previous reviews have extensively summarized its chemical constituents and pharmacological activities, a systematic understanding of how host trees dictate its quality and safety remains largely fragmented. This review bridges this gap by proposing a "host-governed quality paradigm." By integrating historical records with modern scientific findings, we critically evaluate the molecular mechanisms underlying host-parasite interactions and their impact on medicinal quality. We highlight that host species influence Taxilli Herba across three critical dimensions: (i) chemical composition, comprising both intrinsic bioactive compounds and host-derived metabolites; (ii) toxicity profile, where even hosts lacking cardiac glycosides may pose potential safety hazards; and (iii) pharmacological activity, where host identity modulates therapeutic potency and traditional medicinal properties (e.g., "cold" vs. "warm" nature). Importantly, we highlight that the cardiac glycoside test specified in the current Chinese Pharmacopoeia is insufficient to ensure the safety of Sangjisheng derived from diverse hosts. To address these challenges, we propose a host-governed quality paradigm comprising four pillars: (1) mechanistic studies on host-parasite interactions; (2) revision of pharmacopeial standards to restrict approved sources; (3) promotion of standardized cultivation using safe host species (e.g.,

Indexed as

Drugs, Chinese HerbalHost-Parasite InteractionsPlants, MedicinalTaxaceaeAnimalsHumansDrugs, Chinese Herbalhost treesmateria medicamedicinal material qualityquality managementTaxilli Herba

Identifiers

PMID42650799
PMCPMC13511735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.